Suppr超能文献

《简易躁动评估量表(BARS)挪威语版在痴呆症中的信度和效度》。

Reliability and validity of the Norwegian version of the Brief Agitation Rating Scale (BARS) in dementia.

机构信息

Department of Old Age Psychiatry, Norway Innlandet Hospital Trust, Reinsvoll, Norway.

出版信息

Aging Ment Health. 2011 Mar;15(2):252-8. doi: 10.1080/13607863.2010.519318. Epub 2010 Dec 6.

Abstract

OBJECTIVE

To examine the test-retest reliability and validity of the Norwegian Brief Agitation Rating Scale (BARS), a short form of the Cohen-Mansfield Agitation Inventory (CMAI) assessing the frequency of agitation in dementia.

METHODS

We investigated the internal consistency, test-retest reliability and the validity of BARS. In the validity study, we compared the BARS scores with the Neuropsychiatric Inventory--Nursing Home Version subscale Agitation/Aggression (NPI-NH/AA) and the Cornell Scale for Depression in Dementia subscale Agitation (CSDD/A).

RESULTS

In the reliability study, Cronbach's alpha was 0.76; the test-retest reliability of the BARS showed a Spearman's rho of 0.64, but this increased to 0.86 when we deleted the item 'complaining'. In the validation study, the BARS score correlated with the NPI-NH/AA and the CSDD/A scores, Spearman's rho 0.55 and 0.52, respectively. These correlations changed when controlling for the Clinical Dementia Rating (CDR) Scale stages. The highest correlations between the BARS and the NPI-NH/AA and the BARS and the CSDD/A were found among patients with CDR score 2.

CONCLUSIONS

The study indicates that the Norwegian version of BARS is a reliable and valid instrument to test agitation in dementia, but a version without the item 'complaining' would be better.

摘要

目的

考察挪威简短激越评定量表(BARS)的复测信度和效度,该量表是评估痴呆患者激越频率的 Cohen-Mansfield 激越量表(CMAI)的简短形式。

方法

我们研究了 BARS 的内部一致性、复测信度和效度。在效度研究中,我们将 BARS 评分与神经精神问卷-养老院版激越/攻击亚量表(NPI-NH/AA)和痴呆康奈尔量表激越亚量表(CSDD/A)进行了比较。

结果

在可靠性研究中,Cronbach's alpha 为 0.76;BARS 的复测信度显示 Spearman's rho 为 0.64,但删除“抱怨”项后增加到 0.86。在验证研究中,BARS 评分与 NPI-NH/AA 和 CSDD/A 评分相关,Spearman's rho 分别为 0.55 和 0.52。当控制临床痴呆评定量表(CDR)阶段时,这些相关性发生了变化。在 CDR 评分为 2 的患者中,BARS 与 NPI-NH/AA 之间以及 BARS 与 CSDD/A 之间的相关性最高。

结论

该研究表明,挪威版 BARS 是一种可靠有效的测试痴呆患者激越的工具,但没有“抱怨”项的版本会更好。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验